FDA-Drug2026-03-11Class IIPROCESSING DEFECT
New Life Pharma Tirzepatide injection recalled for sterility concerns
What this means
New Life Pharma LLC is recalling Tirzepatide 10mg multi-dose vials (Lot 240709, expiration 7/31/2026) because the manufacturer cannot confirm the product is sterile. The vials were distributed in Ohio. No injuries have been reported.
- Check if you have Tirzepatide from New Life Pharma with Lot 240709
- Do not use the recalled vials
- Contact your pharmacy or healthcare provider for a replacement or alternative
The agency's original wording
Hazard
Lack of Assurance of Sterility
Intended for
Adults
Illnesses reported
None reported
Sold states
OH
Affected count
23 vials
Manufactured in
265 Livingston St, N/A, Northvale, NJ, United States
Products
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0394-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.